Rapid Dose Therapeutics names Dr Rina Carlini new vice president, Research & Innovation
7 June 2019 -

Rapid Dose Therapeutics Corporation (CSE: DOSE), a Canadian company involved in drug delivery solutions, has named Dr Rina Carlini as its new vice president, Research & Innovation, it was reported yesterday.

Dr Carlini is a scientist and management executive with 25 years of experience in technology innovation, product development, and commercialisation within the sectors of health technology, life science, IoT, artificial intelligence, advanced manufacturing, and nanotechnology.

Her professional experience covers diverse industries and leadership roles, including pharma drug discovery R&D (Merck, Syntex), as director of Nanotechnology for Xerox Innovation Group (Canada), director of Commercialisation at GreenCentre Canada, and president & CEO of Haltech Regional Innovation Centre. In addition, Carlini is the inventor of more than 100 US patents; co-author of 20+ peer-reviewed research articles; serves on the board for Waterloo Institute for Nanotechnology, Concordia University's Gina Cody School of Engineering, and as an expert reviewer for several Canadian funding agencies (OCE, NSERC, CFI).

Mark Upsdell, president and CEO, said, 'We are excited to have Rina join the RDT team and we look forward to engaging her wealth of expertise as RDT enters the next advancement of our global growth within the drug delivery technology sector.'